These findings are intriguing, given that a correlation has been already suggested between dysregulated insulin signaling and ovarian steroidogenic function, namely in Polycystic Ovary Syndrome (PCOS) (Fedeli et al., 2023). The gene discussed is INS; the disease is polycystic ovary syndrome.